Investigator
Yu Chen
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · funded by NIA, NCI, NIAID
- Companies
- 1
- Grants
- 11
- Non-dilutive funding
- $10M
- First award
- Sep 14, 2001
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Mar 1, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Nanjing Leads Biolabs Co.,Ltd100momentum
OncologyFiled/Approved
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- K99
Mapping cerebellar influence in FTD: unraveling the role of the cerebellum in social cognition and clinical trajectory
$120kMar 1, 2026NIAUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11283615 (opens the source filing in a new tab)
- R01
A prospective study of viral infections and subsequent risk of Alzheimer’s disease
$713kFeb 1, 2026NIANEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11229846 (opens the source filing in a new tab)
- R01
Midlife circulating autoantibodies and the risk of Alzheimer’s disease in Women
$725kJan 1, 2026NIANEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11304392 (opens the source filing in a new tab)
- U01
A prospective study of circulating autoantibodies and breast cancer risk in the NYU Women’s Health Study
$703kSep 1, 2025NCINEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11044553 (opens the source filing in a new tab)
- R01
Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma
$1.2MSep 1, 2025NCISLOAN-KETTERING INST CAN RESEARCHNIH RePORTER · 11144600 (opens the source filing in a new tab)
- R01
Clostridioides difficile Zinc-binding PBPs as anti-sporulation targets
$2.9MAug 1, 2025NIAIDUNIVERSITY OF SOUTH FLORIDANIH RePORTER · 11234622 (opens the source filing in a new tab)
- R01
Exposure to Metal-Mixtures and Coronary Heart Disease Across Diverse Populations
$692kSep 24, 2024NIEHSNEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11196717 (opens the source filing in a new tab)
- SC3
Iodine Catalyzed Cross-Coupling Reactions
$116kJun 15, 2022NIGMSQUEENS COLLEGENIH RePORTER · 11092123 (opens the source filing in a new tab)
- R01
Evolution and inhibition of carbapenemase in beta-lactam resistance
$779kApr 6, 2021NIAIDUNIVERSITY OF SOUTH FLORIDANIH RePORTER · 11051272 (opens the source filing in a new tab)
- P50
SPORE in Prostate Cancer
$2.1MSep 14, 2001NCISLOAN-KETTERING INST CAN RESEARCHNIH RePORTER · 11173716 (opens the source filing in a new tab)
- P50
Core D: Preclinical Models Core
$213kSep 14, 2001NCISLOAN-KETTERING INST CAN RESEARCHNIH RePORTER · 11173744 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources